Unknown Organization (20240347190). MASK-BASED DIAGNOSTIC UTILIZING AI ALGORITHMS FOR IMPROVED PATIENT OUTCOMES simplified abstract
Contents
MASK-BASED DIAGNOSTIC UTILIZING AI ALGORITHMS FOR IMPROVED PATIENT OUTCOMES
Organization Name
Inventor(s)
John J. Daniels of Madison CT (US)
MASK-BASED DIAGNOSTIC UTILIZING AI ALGORITHMS FOR IMPROVED PATIENT OUTCOMES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240347190 titled 'MASK-BASED DIAGNOSTIC UTILIZING AI ALGORITHMS FOR IMPROVED PATIENT OUTCOMES
The abstract describes a mask-based diagnostic system for remote patient monitoring that collects chemical biomarker data and non-chemical biometric data in a non-invasive manner. The system can monitor various medical conditions such as cardiovascular disease, lung cancer, diabetes, and respiratory diseases.
- The system includes a mask with an exhaled breath condensate (EBC) collector for chemical biomarker testing.
- Non-chemical biometric data like temperature, heart rate, and blood oxygen levels can be obtained using a wearable electronic device.
- Collected data is wirelessly transmitted to a remote server for aggregation, analysis, and interpretation using artificial intelligence (AI) algorithms.
- AI algorithms detect patterns and trends in patient data for drug discovery, health issue identification, and treatment plan adjustments.
- The system improves patient outcomes by providing real-time monitoring, early health issue detection, and personalized treatment options.
Potential Applications: - Remote patient monitoring for various medical conditions - Drug discovery and development - Personalized healthcare management
Problems Solved: - Non-invasive data collection for patient monitoring - Early detection of health issues - Personalized treatment options
Benefits: - Real-time monitoring - Early health issue detection - Personalized treatment plans
Commercial Applications: Title: Mask-Based Diagnostic System for Remote Patient Monitoring This technology can be used in healthcare facilities, research institutions, and pharmaceutical companies for remote patient monitoring, drug development, and personalized healthcare management. The market implications include improved patient outcomes, cost-effective healthcare delivery, and enhanced research capabilities.
Questions about Mask-Based Diagnostic System for Remote Patient Monitoring: 1. How does the mask-based diagnostic system collect chemical biomarker data? The mask includes an exhaled breath condensate (EBC) collector that tests for chemical biomarkers in exhaled breath.
2. What types of non-chemical biometric data can be obtained using the wearable electronic device? Non-chemical biometric data such as temperature, heart rate, and blood oxygen levels can be collected using the wearable electronic device.
Original Abstract Submitted
a mask-based diagnostic (mbd) system for remote patient monitoring that collects chemical biomarker data and non-chemical biometric data from patients in a non-invasive manner. the mbd can be used to monitor various medical conditions, including cardiovascular disease, lung cancer, diabetes, and respiratory diseases. the system consists of a mask having an exhaled breath condensate (ebc) collector that tests for chemical biomarkers in ebc. non-chemical biometric data, such as temperature, heart rate, and blood oxygen levels can also be obtained using a wearable electronic device. the collected data is transmitted wirelessly to a remote server for aggregation, analysis, and interpretation using artificial intelligence (ai) algorithms. the ai algorithms detect patterns and trends in the patient data, which can be used for drug discovery, to identify health issues, adjust treatment plans, etc. the mbd can improve patient outcomes by providing real-time monitoring, early detection of health issues, and personalized treatment options.
